Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years.
- Resource Type
- letter
- Authors
- Hayley King; Deshpande, Sanjay; Woodbridge, Tamsin; Hilliard, Tom; Standing, Jon; Lewis, Mary; Ward, Lesley; Finn, Adam; Roderick, Marion; King, Hayley
- Source
- Archives of Disease in Childhood; Feb2022, Vol. 107 Issue 2, p205-207, 3p
- Subject
- IMMUNIZATION of children
MEDICAL personnel
COVID-19 vaccines
CHILD health services
MEDICAL care
COVID-19 pandemic
CHILDREN with cerebral palsy
ORPHANS
- Language
- ISSN
- 00039888